ID   TMD2
AC   CVCL_5377
SY   Tokyo Medical and Dental university 2
DR   Wikidata; Q54972691
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1283544;
RX   PubMed=1912566;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=TMD2
CC   Population: Japanese.
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
RX   PubMed=1912566; DOI=10.1182/blood.V78.7.1789.1789;
RA   Tohda, Shuji
RA   Nara, Nobuo
RA   Murohashi, Ikuo
RA   Aoki, Nobuo
RT   "Establishment of an interleukin-3-dependent leukemic cell line from a
RT   patient with chronic lymphocytic leukemia in the acute phase.";
RL   Blood 78:1789-1794(1991).
//
RX   PubMed=1283544; DOI=10.3109/10428199209049786;
RA   Nara, Nobuo
RT   "Colony-stimulating factor (CSF)-dependent growth of two leukemia cell
RT   lines.";
RL   Leuk. Lymphoma 7:331-335(1992).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//